| Document |
Document Title |
|
WO/2014/061470A1 |
Provided are: a method for producing an N,N-dialkylhomofarnesic acid amide, which is a precursor of (±)-3a,6,6,9a-tetramethyldodecahydronaphtho[2,1-b]furan that is useful as a fragrance, with a high raw material recovery ratio, high pur...
|
|
WO/2014/062428A1 |
This invention provides a method for the synthesis of a 2-amino-4,6-dimethoxybenzamide and other benzamides of Compound I: wherein R1, R2, R3, and R4 each independently represent a hydrogen, a C1-C6 alkyl, or a C1-C6 alkoxy; and wherein ...
|
|
WO/2014/061467A1 |
Provided is a liquid composition having low environmental impact, and having the property of thickening or gelling through the application of strain. This liquid composition contains the following components (A), (B), (C), and (D). Compo...
|
|
WO/2014/056421A1 |
Provided are a 1-cyan-1-(7-methoxyl-1-naphtyl) methanol ester compound, and preparation method and use thereof in the preparation of agomelatine intermediate 2-(7-methoxyl-1-naphtyl) ethylamine. Also provided is an agomelatine preparatio...
|
|
WO/2014/054158A1 |
The present invention provides an imide compound expressed by general formula (1), and an insecticide containing the imide compound. In the formula, A1, A2, A3, and A4 each represent a carbon atom, a nitrogen atom, or an oxidized nitroge...
|
|
WO/2014/052091A1 |
The present invention relates to a process for the preparation of iodinated X-ray contrast agents and in particular to key intermediates thereof. More particularly, the invention relates to a work-up process for preparation of a compound...
|
|
WO/2014/051971A1 |
A multistage process for the preparation of methacrylic acid and esters thereof via the hydrolysis of ACH, cracking the hydrolysis products, and converting the cracked products to the desired acid or ester, wherein the average temperatur...
|
|
WO/2014/052092A1 |
The present invention relates to a process for the preparation of Ioforminol, a contrast agent useful in X-ray imaging. More particularly, the invention relates to preparation of Ioforminol from a compound mixture comprising 1-formylamin...
|
|
WO/2014/050426A1 |
The present invention provides a method for producing a liquid crystal composition in a single step, said liquid crystal composition using two or more different types of carboxylic acid as a type of raw material, and having the ability t...
|
|
WO/2014/041015A1 |
Stabilised amorphous form of the compound of formula (I): Medicaments.
|
|
WO/2014/037308A1 |
Disclosed is a method for the synthesis of N-H or N-alkyl 2-propynamides useful as intermediate in the manufacture of pharmaceutically active ingredients.
|
|
WO/2014/037444A1 |
Disclosed is a novel process for the reduction of nitro groups to amino derivatives, based on the use of trichlorosilane and an organic base, which is efficient from the chemical standpoint and of wide general applicability.
|
|
WO/2014/034124A1 |
Provided is a chemical reaction which omits or simplifies treatment after reaction. This problem is solved by a method for producing a product by a chemical reaction which comprises: (A) a step of producing a product by reacting a substa...
|
|
WO/2014/030038A1 |
A process of producing N-acyl amino acid based surfactants of Formula (I), wherein, R is selected from C6 to C22 alkyl group, R1 is selected from H, C1 to C4 alkyl, R2 is selected from all groups on a carbon of natural amino acids, R3 is...
|
|
WO/2014/022879A1 |
The present invention relates to compounds for the treatment of mTOR (mammalian Target Of Rapamycin) pathway related diseases. Specifically, the present invention relates to the use of aminoactonitrile derivatives (AADs) in the treatment...
|
|
WO/2014/024989A1 |
In order to address the problem of establishing a method for recovering coumaramide obtained by treating cellulosic biomass using an ammonia-containing treatment agent, this method for producing coumaramide is characterized by including:...
|
|
WO/2014/019995A1 |
The present invention relates to a novel process for preparing substituted biphenyls of the formula (III) by reacting arenes of the formula (I) with arenes of the formula (11) in the presence of a transition metal catalyst, and of at lea...
|
|
WO/2014/014035A1 |
The invention pertains to a novel pyrophosphoric acid ester compound represented by formula (1) and a bisphosphoric acid ester compound represented by formula (2). In the formulas, R is an aryl group, organic silyl group, or halogen atom...
|
|
WO/2014/015276A1 |
The present invention provides a compound, and method of inhibiting the activity of a Fatty Acid Binding Protein (FABP) comprising contacting the FABP with a compound, having the structure: Formula (I).
|
|
WO/2014/009767A1 |
The present invention relates to an improved and one-pot process for the preparation of 1-Aryl 2-aminomethyl cyclopropane carboxyamide (z) derivatives, their isomers of formula (I) or its pharmaceutically acceptable salt thereof wherein ...
|
|
WO/2014/008103A1 |
Improved processes for making an N-acyl amino acid salt from a fatty alkyl ester or a polyol ester are disclosed. Each process uses a polyol selected from glycerin or propylene glycol in an amount effective to keep the reaction mixture f...
|
|
WO/2014/008350A1 |
The present invention provides a process for preparing a bicyclic amine derivative of the for-mula (Ia) or (Ib), (Formulae (Ia) (Ib)) comprising the rhodium-catalyzed asymmetric hydrogenation of an enamine of the formula (II), (Formula (...
|
|
WO/2014/005196A1 |
The present invention provides processes for producing amine-containing compounds such as diammonium salts and amino acid derivatives comprising the steps of subjecting a salt of an amine bearing an unsaturated group to a self-metathesis...
|
|
WO/2014/001939A1 |
An improved process for the preparation of agomelatine of formula (I) and a new process for the preparation of crystalline form I of agomelatine are provided.
|
|
WO/2013/187480A1 |
An aim of the present invention is to provide a novel cyclic depsipeptide derivative and a pest control agent comprising the same. According to the present invention, a compound represented by formula (1) or a stereoisomer thereof, a pes...
|
|
WO/2013/186248A1 |
The present invention discloses a method for preparing 3-amino-N-cyclopropyl-2-hydroxyl-hexanamide. The invention relates to the technical field of the preparation of pharmaceutical intermediates. The method uses trans-2-hexenoic acid as...
|
|
WO/2013/181697A1 |
The present invention relates to compounds that can be used link substrates to molecules, typically for biological applications such as imaging and the like. The compounds contain a cyclooctyne which is joined, via a linking group, to a ...
|
|
WO/2013/182023A1 |
The present invention provides a carbon fiber surface modifier, a modified carbon fiber, composites, and preparation methods therefor. The general structural formula of the carbon fiber surface modifier is as represented by formula (I): ...
|
|
WO/2013/178450A1 |
The invention relates to a method for the synthesis of a compound according to formula I comprising the following steps: a) reacting a Dane salt according to formula II and a Dane salt according to formula III with a coupling reagent; b)...
|
|
WO/2013/178451A1 |
The invention relates to a method for the synthesis of a compound according to formula I comprising the following steps: a) reacting a N-carboxyanhydride according to formula II and a N-carboxy- anhydride according to formula III with a ...
|
|
WO/2013/175498A2 |
The present invention relates to novel compounds represented by the Formula (I), (The formula I should be inserted here) Wherein, n represents alkyl chain having from 8 to 30 carbon atoms; m represents alkyl chain having from 1 to 6 carb...
|
|
WO/2013/171767A1 |
The present invention relates to an improved process for the preparation of renin inhibitor Aliskiren intermediates of Formula-II and further conversion into Aliskiren and its pharmaceutically acceptable salts.
|
|
WO/2013/161642A1 |
A photochromic curable composition of the present invention is characterized by containing, as (A) radically polymerizable monomer components, (A1) a (meth)acryl amide polymerizable monomer which has 2-6 (meth)acryloyloxy groups and 2-6 ...
|
|
WO/2013/154689A1 |
Disclosed is a method involving reacting a deprotonated mono- or dialkanol amine with one or more C4 to about C75 fatty acid monoalcohol esters.
|
|
WO/2013/153754A1 |
A method for producing a β-alkoxypropionamide, wherein a β-alkoxypropionamide represented by formula (3) is produced by reacting a β-alkoxypropionic acid ester represented by formula (1) and an amine represented by formula (2) in the ...
|
|
WO/2013/150988A1 |
Provided is a method for producing an aromatic amide derivative represented by general formula (4), which comprises a step wherein an aromatic amide derivative represented by general formula (1) and a haloalkyl compound represented by ge...
|
|
WO/2013/144101A1 |
The present invention relates to a novel process for preparing cis-alkoxy-substituted spirocyclic phenylacetylamino acid esters and cis-alkoxy-substituted spirocyclic 1-H-pyrrolidine-2,4-dione derivatives and also novel intermediates and...
|
|
WO/2013/143812A1 |
The present invention relates to a method for hydrolysing acetone cyanohydrin (ACH) by sulphuric acid in the context of the ACH-sulpho method for producing methacrylic acid (MAA) or methyl methacrylate (MMA).
|
|
WO/2013/139627A1 |
Process for making an amide of a carboxylic acid by reacting an amine of the formula (I) H-NR1R2, the integers being defined as being equal or different, R1 being selected from C1-C4-alkyl, R2 being selected from hydrogen and C1-C4-alkyl...
|
|
WO/2013/141576A1 |
The present invention relates to a method for stabilizing ramalin and a stabilized ramalin solution, and more specifically to a method for stabilizing ramalin and a solution of thus stabilized ramalin, the method for stabilizing ramalin ...
|
|
WO/2013/136061A1 |
New polymorphic form of a long-acting beta-2 adrenoceptor agonist A new polymorphic form of arformoterol tartrate, designated as form D, is provided and which is characterised by at least one of the following: (i) a powder X-ray diffract...
|
|
WO/2013/136265A1 |
Process for the preparation of a cyclopropylamide compound which is useful as a structural unit in a process for the preparation of a viral protease inhibitor.
|
|
WO/2013/131043A1 |
The present invention provides organic molecules and methods thereof for reactions between organoboron reagents and double bonds, such as imines or carbonyls, to stereoselectively provide chiral products including amines and alcohols, en...
|
|
WO/2013/130849A1 |
This invention relates to novel substituted dioxopiperidinyl phthalimide derivatives and pharmaceutically acceptable acid addition salts thereof. The invention also provides compositions comprising a compound of this invention and the us...
|
|
WO/2013/128477A1 |
An efficient and eco-friendly process for producing amide compounds comprising contacting a primary amine with molecular oxygen-containing gas, solvent and ammonia solution in the presence of a non-precious metal-containing ordered, meso...
|
|
WO/2013/121443A1 |
The present invention relates to an improved process for the preparation of pure compound of Formula-II, which is an intermediate in the preparation of Aliskiren and further conversion of compound of Formula-II into Aliskiren or its phar...
|
|
WO/2013/122130A1 |
Provided is a production method for a hydroxy-carboxylic acid amide compound, wherein a hydroxy-carboxylic acid amide compound is obtained by performing an amide condensation reaction between an α- or β-hydroxy-carboxylic acid compound...
|
|
WO/2013/120257A1 |
Provided is a method for synthesizing a laevo-p-hydroxyphenylglycine compound, comprising: (1) subjecting an amine compound with a glyoxylic acid ester compound to a nucleophilic addition reaction; subjecting the product obtained in step...
|
|
WO/2013/118751A1 |
An amide compound can be produced efficiently by reacting a carboxylic acid ester compound and a primary or secondary monoamine compound in the presence of a catalyst obtained by bonding at least one alkoxy group to a metal or semimetal ...
|
|
WO/2013/104774A1 |
The present invention relates to the preparation of optically resolved chiral compounds of β-amino acid type active pharmaceutical ingredients (API), more specifically to β-aminobutyryl substituted compounds and especially β-aminobuty...
|
